Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,746Revenue $M512Net Margin (%)-9.5Z-Score8.2
Enterprise Value $M14,834EPS $-0.3Operating Margin %-0.9F-Score4
P/E(ttm))0Cash Flow Per Share $-1.3Pre-tax Margin (%)-9.5Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio3.2Cash flow > EarningsY
Price/Sales29.55-y EBITDA Growth Rate %0Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-6.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M172ROI % (ttm)-131.6Gross Margin Increase y-yN

Gurus Latest Trades with INCY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INCYKen Fisher 2014-12-31 Add$45.6 - $78.89
($65.29)
$ 87.5434%Add 97.08%14,870
INCYMariko Gordon 2014-12-31 Sold Out -0.05%$45.6 - $78.89
($65.73)
$ 87.5433%Sold Out0
INCYKen Fisher 2014-09-30 Reduce$45.35 - $55.78
($50.07)
$ 87.5475%Reduce -38.28%7,545
INCYVanguard Health Care Fund 2014-06-30 Add0.68%$43.1 - $56.39
($50.98)
$ 87.5472%Add 95.66%9,591,143
INCYKen Fisher 2014-06-30 Buy $43.1 - $56.39
($50.98)
$ 87.5472%New holding, 12225 sh.12,225
INCYMariko Gordon 2014-06-30 Reduce-0.19%$43.1 - $56.39
($50.98)
$ 87.5472%Reduce -78.93%23,728
INCYGeorge Soros 2014-06-30 Sold Out -0.01%$43.1 - $56.39
($50.98)
$ 87.5472%Sold Out0
INCYGeorge Soros 2014-03-31 Buy 0.01%$49.94 - $68.83
($61.83)
$ 87.5442%New holding, 23200 sh.23,200
INCYMariko Gordon 2013-12-31 Reduce-0.06%$34.71 - $51.34
($43.45)
$ 87.54102%Reduce -20.5%128,959
INCYVanguard Health Care Fund 2013-06-30 Add0.05%$19.07 - $24.49
($21.85)
$ 87.54301%Add 21.52%3,807,443
INCYVanguard Health Care Fund 2013-03-31 Buy 0.29%$16.61 - $24.95
($20.44)
$ 87.54328%New holding, 3133100 sh.3,133,100
INCYGeorge Soros 2011-03-31 Sold Out $13.37 - $16.56
($14.71)
$ 87.54495%Sold Out0
INCYGeorge Soros 2010-12-31 Buy $14.51 - $17.17
($16.13)
$ 87.54443%New holding, 15000 sh.15,000
INCYBill Gates 2009-06-30 Sold Out -0.01%$2.06 - $3.84
($2.79)
$ 87.543038%Sold Out0
INCYJean-Marie Eveillard 2009-03-31 Sold Out $2.14 - $3.78
($2.9)
$ 87.542919%Sold Out0
INCYJean-Marie Eveillard 2008-12-31 Buy $2.82 - $4.89
($3.8)
$ 87.542204%New holding, 11300 sh.11,300
INCYGeorge Soros 2008-09-30 Sold Out -0.02%$7.31 - $10.23
($9.2)
$ 87.54852%Sold Out0
INCYGeorge Soros 2008-06-30 Add0.01%$7.6 - $11.27
($9.8)
$ 87.54793%Add 52.29%74,558
INCYGeorge Soros 2008-03-31 Reduce-0.01%$9.27 - $12.36
($10.6)
$ 87.54726%Reduce -57.34%48,958
INCYGeorge Soros 2007-12-31 Reduce-0.03%$7.85 - $10.59
($8.9)
$ 87.54884%Reduce -45.42%114,758
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INCY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
INCY Ken Fisher 2014-12-3114,8700.010+97.08%
INCY Vanguard Health Care Fund 2014-12-3110,174,3435.921.7
INCY Mariko Gordon 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


INCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Siegel Eric H.EVP, General Counsel 2015-02-25Sell13,333$852.99view
Daly James MEVP, Chief Commercial Officer 2015-02-24Sell11,112$82.196.51view
ARIKO BARRY ADirector 2015-02-18Sell20,000$78.4311.62view
SWAIN PAULA JEVP, Human Resources 2015-02-17Sell17,500$76.913.84view
Levy Richard SEVP, Chief Drug Dev&Medical Of 2015-02-17Sell12,000$76.913.84view
FRIEDMAN PAUL ADirector 2015-02-13Sell120,000$74.3217.79view
Levy Richard SEVP, Chief Drug Dev&Medical Of 2015-02-06Sell25,000$75.1116.55view
Siegel Eric H.EVP, General Counsel 2015-01-26Sell13,542$79.859.63view
Daly James MEVP, Chief Commercial Officer 2015-01-23Sell11,109$77.6812.69view
SWAIN PAULA JEVP, Human Resources 2015-01-20Sell17,500$74.1718.03view

Press Releases about INCY :

Quarterly/Annual Reports about INCY:

News about INCY:

Articles On GuruFocus.com
Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc. Jun 09 2014 
Weekly Insider Sells Highlight: ARMK, INCY, ESC, HUN Jun 08 2014 
Weekly Insider Sells Highlight: CPN, INCY, GPK, CODE Feb 23 2014 
Weekly CFO Sells Highlight: Pandora Media Inc, Incyte Corp Ltd, Google Inc, American Airlines Group Feb 24 2014 
Weekly CEO Sells Highlight: ExOne Co, Atmel Corporation, Best Buy and Incyte Corp Ltd. Sep 22 2013 
Weekly CFO Sells Highlight: INTU, INCY, RLD, MIDD, XONE Sep 15 2013 
Weekly CEO Sells Highlight: DIS, LMT, INCY, ADBE May 14 2012 
Weekly Top Insider Buys: VTR, INCY, FULT, HMA, CMC Jan 23 2012 
04 stocks with insider buying of more than $1.5 million since beginning of 2012 Jan 22 2012 
Weekly CFO Sales Highlight: EPIQ, INCY, AVB, JOSB, PCS, FLO Jun 12 2011 


More From Other Websites
Incyte Sponsors First Observational Study Designed to Understand the Impact of Polycythemia Vera –... Feb 26 2015
Incyte Sponsors First Observational Study Designed to Understand the Impact of Polycythemia Vera –... Feb 26 2015
Eli Lilly's BIL Filing Delayed, Baricitinib Scores in Phase III - Analyst Blog Feb 24 2015
Baricitinib Superior to Placebo in Reducing Rheumatoid Arthritis Disease Activity in Second Phase 3... Feb 23 2015
Baricitinib Superior to Placebo in Reducing Rheumatoid Arthritis Disease Activity in Second Phase 3... Feb 23 2015
INCYTE CORP Financials Feb 21 2015
INCYTE CORP Files SEC form 8-K, Other Events Feb 20 2015
10-K for Incyte Corp. Feb 19 2015
INCYTE CORP Files SEC form 10-K, Annual Report Feb 17 2015
Incyte to Present at Upcoming Investor Conferences Feb 17 2015
Incyte to Present at Upcoming Investor Conferences Feb 17 2015
Incyte Corporation (INCY): New Analyst Report from Zacks Equity Research - Zacks Equity Research... Feb 16 2015
Incyte Posts Wider-than-Expected Q4 Loss; Revenues Miss - Analyst Blog Feb 13 2015
Incyte reports 4Q loss Feb 12 2015
Incyte reports 4Q loss Feb 12 2015
Should You Sell Incyte (INCY) Before Earnings? - Tale of the Tape Feb 12 2015
Incyte Corp Earnings Call scheduled for 8:30 am ET today Feb 12 2015
INCYTE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 12 2015
Q4 2014 Incyte Corp Earnings Release - 07:00 am ET Feb 12 2015
Incyte Reports 2014 Fourth-Quarter and Year-End Financial Results; Provides 2015 Financial Guidance;... Feb 12 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK